Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Screening for colorectal cancer by faecal occult blood test: why people choose to refuse.

Worthley DL, Cole SR, Esterman A, Mehaffey S, Roosa NM, Smith A, Turnbull D, Young GP.

Intern Med J. 2006 Sep;36(9):607-10.

PMID:
16911554
2.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
3.
4.

A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice.

Multicentre Australian Colorectal-neoplasia Screening (MACS) Group..

Med J Aust. 2006 Jun 5;184(11):546-50.

PMID:
16768659
5.

Determinants of participation in colorectal cancer screening with faecal occult blood testing.

von Euler-Chelpin M, Brasso K, Lynge E.

J Public Health (Oxf). 2010 Sep;32(3):395-405. doi: 10.1093/pubmed/fdp115. Review.

6.

Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.

Keller R, Schätzle A, Flieger D, Christl SU, Fischbach W.

Z Gastroenterol. 2003 Jul;41(7):655-8.

PMID:
12858236
7.

Reasons for non-compliance in colorectal cancer screening with fecal occult blood test.

Li T, Nakama H, Wei N.

Eur J Med Res. 1998 Aug 18;3(8):397-400.

PMID:
9707523
8.
9.
10.

Attitudes towards and beliefs about colorectal cancer and screening using the faecal occult blood test within the Italian-Australian community.

Severino G, Wilson C, Turnbull D, Duncan A, Gregory T.

Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):387-94.

11.

The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.

Almog R, Ezra G, Lavi I, Rennert G, Hagoel L.

Eur J Cancer Prev. 2008 Oct;17(5):430-7. doi: 10.1097/CEJ.0b013e328305a0fa.

PMID:
18714185
12.

Colorectal cancer mass screening event utilising quantitative faecal occult blood test.

Chew MH, Suzanah N, Ho KS, Lim JF, Ooi BS, Tang CL, Eu KW.

Singapore Med J. 2009 Apr;50(4):348-53.

13.

Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.

van Rijn AF, van Rossum LG, Deutekom M, Laheij RJ, Fockens P, Bossuyt PM, Dekker E, Jansen JB.

J Public Health (Oxf). 2008 Dec;30(4):461-5. doi: 10.1093/pubmed/fdn063.

14.

Colorectal cancer screening: optimal compliance with postal faecal occult blood test.

King J, Fairbrother G, Thompson C, Morris DL.

Aust N Z J Surg. 1992 Sep;62(9):714-9.

PMID:
1520154
15.

Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.

Ritvo P, Myers R, Del Giudice ME, Pazsat L, Cotterchio M, Howlett R, Mai V, Brown P, Sullivan T, Rabeneck L.

Can Fam Physician. 2009 Feb;55(2):176-177.e4.

16.
17.

Participation in faecal occult blood screening for colorectal cancer.

Dent OF, Bartrop R, Goulston KJ, Chapuis PH.

Soc Sci Med. 1983;17(1):17-23.

PMID:
6844949
19.

A pilot study of participation in faecal occult blood testing and screening colonoscopy after health education in Hong Kong.

Wong BC, Chan AO, Wong KW, Ching CK, Wong WM, Tam S, Lai KC, Chan CK, Yuen MF, Lam SK.

Eur J Cancer Prev. 2005 Apr;14(2):181-4.

PMID:
15785323
20.

Different faecal sampling methods alter the acceptability of faecal occult blood testing: a cross sectional community survey.

Ellis RJ, Wilson S, Holder RL, McManus RJ.

Eur J Cancer. 2007 Jun;43(9):1437-44.

PMID:
17475476
Items per page

Supplemental Content

Support Center